ESHRE 2026: Seminal Plasma Test Anticipates Sperm Retrieval – European Medical Journal

A recent study presented at the European Society of Human Reproduction and Embryology (ESHRE) 2026 conference revealed that a seminal plasma test could effectively predict successful sperm retrieval in patients undergoing fertility treatments. This innovative test uses biomarkers found in seminal plasma to assess the likelihood of obtaining viable sperm from individuals with male factor infertility.

Current sperm retrieval techniques, such as testicular sperm extraction (TESE) and percutaneous sperm aspiration (PESA), often require multiple attempts and can be invasive. However, with the introduction of this predictive test, clinicians may be able to enhance their decision-making process, offering better-targeted approaches for patients with compromised sperm production or quality.

The studys authors emphasize the importance of early and accurate assessments in improving clinical outcomes for couples facing infertility challenges. Further research is necessary to validate the tests effectiveness and to potentially incorporate it into standard practice to optimize treatment strategies for male infertility.

This pioneering work represents a significant advancement in reproductive medicine, potentially decreasing the physical and emotional burdens on patients undergoing assisted reproductive technologies (ART). The European Society of Human Reproduction and Embryology continues to be at the forefront of developing innovative solutions and improving patient outcomes in the field of reproductive health.